| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS42000526 | EBV | ENSG00000074410.14 | protein_coding | CA12 | No | No | 771 | B3KUB4 O43570 |
| TVIS10040395 | HBV | ENSG00000074410.14 | protein_coding | CA12 | No | No | 771 | B3KUB4 O43570 |
| TVIS10040396 | HBV | ENSG00000074410.14 | protein_coding | CA12 | No | No | 771 | B3KUB4 O43570 |
| TVIS44011028 | HTLV-1 | ENSG00000074410.14 | protein_coding | CA12 | No | No | 771 | B3KUB4 O43570 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | CA12 |
|---|---|
| DrugBank ID | DB00819 |
| Drug Name | Acetazolamide |
| Target ID | BE0001653 |
| UniProt ID | O43570 |
| Regulation Type | inhibitor |
| PubMed IDs | 18336310 |
| Citations | Mincione F, Scozzafava A, Supuran CT: The development of topically acting carbonic anhydrase inhibitors as antiglaucoma agents. Curr Pharm Des. 2008;14(7):649-54. |
| Groups | Approved; Vet_approved |
| Direct Classification | Thiadiazole sulfonamides |
| SMILES | CC(=O)NC1=NN=C(S1)S(N)(=O)=O |
| Pathways | |
| PharmGKB | PA448018 |
| ChEMBL | CHEMBL20 |
